Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship ...

The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...

San Diego-based Dexcom submitted its 15-day G7 CGM to the FDA in October 2024. The company says its 15-day G7 also meets ...

new continuous glucose monitoring (CGM) system. The San Diego, Calif.-based firm said Thursday that its Dexcom G7 15 Day system had been approved by the FDA to treat people 18 and older with diabetes.

What to do: Check your alert settings and refer to your device's manual to ensure the alerts are working as expected. Some people who use continuous glucose monitors have reported not receiving or ...

including self-glucose monitoring devices and continuous glucose monitoring systems Analyses of the global market trends, with market revenue data (sales figures) for 2021-2022, estimates for 2023 ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and scientific fact-checking for the global public.

1 Continuous glucose monitors (CGMs) are revealing surprising ... sensor that transmits glucose readings to a paired electronic device, offering insights without the need for frequent finger ...

Shares traded 8.5% higher at $72.55. The company, which focuses on glucose biosensing--which measures glucose levels in wearers--said that the Food and Drug Administration has cleared the Dexcom G7 15 ...